Skip to main content

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Verrica Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of VRCA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4950+1
Shares10.2M10.8M+575.0K (+5.6%)
Value$29.9M$29.8M−$158.3K (−0.5%)

New holders (11)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to VRCA in Q4 2022
InstitutionSharesValue% of portfolio
BML Capital Management, LLC1,110,605$3.05M2.92%
Conning Inc.129,013$354.8K0.01%
Ergoteles LLC35,552$97.8K0.00%
Kovitz Investment Group Partners, LLC30,125$83.0K0.00%
Jane Street Group, LLC18,052$49.6K0.00%
Stifel Financial Corp16,125$44.3K0.00%
Spire Wealth Management3,827$11.0K0.00%
Federated Hermes, Inc.237$6520.00%
Coppell Advisory Solutions LLC200$5500.00%
CoreCap Advisors, LLC200$5500.00%
Coppell Advisory Solutions Corp.200$5500.00%

Sold out (10)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of VRCA in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Point72 Asset Management, L.P.485,802$1.42M
Occudo Quantitative Strategies LP17,755$52.0K
Goldman Sachs Group Inc17,594$51.0K
Schonfeld Strategic Advisors LLC13,400$39.0K
HRT Financial LP11,411$33.0K
Virtu Financial LLC10,834$32.0K
Qube Research & Technologies Ltd11,024$32.0K
Cubist Systematic Strategies, LLC9,422$28.0K
Citigroup Inc301$1.00K
China Universal Asset Management Co., Ltd.385$1.00K